GENEO Capital Entrepreneur and UI Investissement support the capital increase of the GBNA Group

The GBNA Group of private clinics calls on GENEO and UI to implement its investment programme and intensify its geographical development in the Nouvelle-Aquitaine region

GBNA: a key player in private hospitalisation in New Aquitaine

Founded in 1967 by Doctor Guy-Paul Guichard, on the site of the current Bordeaux North clinic, the GBNA Group has gradually developed in the Gironde and Pyrénées-Atlantiques. With nearly 1,600 beds and places, 2,350 employees and more than 630 doctors, the GBNA Group is now the leading private player in Gironde and the second largest in New Aquitaine.

GBNA comprises around ten establishments and structures, including Bordeaux Nord Aquitaine (PBNA) and Bordeaux Rive-Droite (PBRD), the Navarre and Marzet clinics in Pau (since the takeover of the Gaucher Group in 2020) and the Ehpad du Béquet in Bègles. The Group is mainly involved in short-stay hospital activities in Medicine, Surgery and Obstetrics and covers all medical specialties: Oncology, All Surgeries, Emergency Medicine, Intensive Care, Nephrology, Imaging, Obstetrics, Ophthalmology.

Over the last ten years, GBNA's growth has enabled it to invest in state-of-the-art equipment (surgical robot, Cyber Knife, PET scan), to increase its capacity and also to offer practice conditions that attract and retain high-level practitioners. The Group is now structured to meet the challenges of demographic and health developments, in particular the ageing of the population and the growth in chronic diseases.

An ambitious investment and territorial development programme

In order to support its development and offer an ever more qualitative range of care, GBNA wished to open its capital to two investors who share the same values and vision.

GBNA's family shareholders have decided to rely on UI's healthcare expertise, which had already supported the Group between 2013 and 2018, and on GENEO Capital Entrepreneur, thanks to its long-term approach and its community of entrepreneurs, to accelerate the implementation of the development project.

This capital increase should enable the Group to consolidate its position as regional leader and to develop its medical project through both organic and external growth. The knowledge of the MCO clinic sector, the Group's dynamics, as well as the close relationship between the investors and the historical shareholders should enable the Group to move forward rapidly with the implementation of these developments.

The Group's Management Board, composed of François Guichard and Pierre Guichard, Chairmen and Chief Executive Officer, Philippe Cruette, is delighted with this transaction: " Thanks to the quality of our partnership with UI Investissement and GENEO Capital Entrepreneur, GBNA is consolidating the forces necessary to implement its ambitions and meet the health challenges of its territory .

Michel Deprez, Managing Partner of UI Investissement, said: " We are very pleased that GBNA's shareholders have once again decided to work with UI to lead this ambitious medical project. It is a sign of the quality of the relationship we have developed together and of the expertise of our health division".

Marc Dupuy, Associate Director at GENEO, adds: " We are proud to support GBNA and its management in its development project, which aims to strengthen the group's medical excellence as well as to carry out an ambitious external growth strategy. We will fully mobilise the resources of the GENEO community in order to deploy a growth pipeline and achieve the ambition of becoming the reference group in the Nouvelle-Aquitaine region.

KEY FIGURES GBNA GROUP

8 specialised polyclinics
1 600 beds and places
2 350 employees and more than 630 doctors
1st private actor in Gironde

STAKEHOLDERS

Investors :

UI Investment: Michel Deprez, Robert Le Roux, Thomas Schmidt, Hanna Tayeb
GENEO Capital Entrepreneur : Marc Dupuy, Louis Charrier

Advice UI Investissement and GENEO Capital Entrepreneur:

Legal (SVZ): Pierre-Emmanuel Chevallier, Chloé Métivier
DD Legal and Tax: PWC Law firms (Suzie Maillot and Catherine Colcanap)
Social SD: PWC Law firms (Bernard Borrely and Eléonore Guesnerot)
DD Financial: PWC Transactions Services (Benoit Cambournac, Laurent Margaillan, Halima Nejjah and Sarah Leroy)

Advice GBNA Group :

M&A (Société Générale): Christophe Pally, Tiphaine Mear, Dimitri Moreau
Legal (Fidal): Anne Méhu

About GBNA

The Groupe Bordeaux Nord Aquitaine (GBNA) is the second largest private group in the Medicine-Surgery-Obstetrics (MCO) sector in New Aquitaine. Founded by a core group of doctors in 1967, its majority family and medical shareholders have voluntarily chosen to develop in their historic regional territory, giving priority to the excellence of its care and proximity to its patients. Within the group's eight health establishments, more than 2,300 employees and 630 doctors treat more than 100,000 patients per year, thus contributing to the public service mission in health.

Press contact: Boris Galinat: 07 86 23 40 79 - b.galinat@bordeauxnord.com

For more information, please visit http://www.gbna-polycliniques.com/

About GENEO Capital Entrepreneur

GENEO Capital Entrepreneur's raison d'être is to give SMEs and SMIs the means to achieve their ambitions, in a sustainable and positive impact approach.

GENEO is an evergreen investment company with a 99-year lifespan. It provides tailor-made capital that adapts to the pace of each company and provides responsiveness and flexibility. GENEO's capital is mainly held by families and entrepreneurs who have brought its resources to more than 225 million euros. These resources are regularly increased as GENEO and the companies it invests develop.

As a business partner, GENEO works alongside you to provide support for the execution of your structuring, growth and transformation projects. The terms of this operational support are adapted to the specific needs of each company and formalised jointly by the GENEO team, the management team and the company's other shareholders in a "Growth Roadmap". This roadmap allows us to mobilise, at the right time, our teams, including our specialised business partners (external growth, positive impact, digital and innovation) who are employees of the management company, as well as our platform of more than 140 independent experts and our Community of 130 families and entrepreneurs, which offers a sharing of experience and a business network that is unprecedented in France.

Finally, to give each generation the means to achieve its ambitions, GENEO allocates a significant part of the team's carried interest to an endowment fund that supports job creation in disadvantaged areas and the reintegration of disadvantaged people into employment.

Passionate about those who make, create and want to move the lines, the only ambition of the GENEO team is to bring the ambition of each entrepreneur to the top.

At GENEO, when we invest, we invest!

Contact: Marc Dupuy : marc@geneocapitalentrepreneur.com / Linkedin / Twitter

For more information, please visit www.geneocapitalentrepreneur.com